How A Compounding Pharmacy Differs From A Retail One

Most pharmacies count out a manufactured product and label it. A compounding pharmacy makes the preparation itself, which places it under a different set of rules.

The practice fills gaps a factory leaves

Manufactured medicines come in fixed strengths and forms. A patient who cannot swallow a tablet, needs a strength that is not made, or reacts to a dye has no commercial option.

Compounding produces a liquid, a cream, a smaller dose or a dye-free version to a specific prescription for a specific patient.

Veterinary work and pediatric dosing are large parts of the field for the same reason: the commercial range does not cover the needed sizes.

Oversight is split between two frameworks

Traditional compounding for an identified patient is regulated primarily by state boards of pharmacy, as part of the practice of pharmacy.

Facilities producing larger batches without individual prescriptions register federally as outsourcing facilities and follow manufacturing quality standards.

The distinction was sharpened after contamination in a large-scale compounding operation caused widespread harm, which prompted the current two-track structure.

Sterile preparation is a separate discipline

Injections, eye preparations and infusions must be sterile, which requires controlled air, validated procedures and testing that a countertop cannot provide.

Standards for sterile compounding are detailed and demanding, and the facilities that meet them are correspondingly more expensive to operate.

Non-sterile work, creams, capsules and suspensions, carries lower risk but still depends on accurate weighing and consistent mixing.

Compounded products are not approved drugs

A compounded preparation has not been evaluated for safety and effectiveness the way an approved product has, because it is made for an individual rather than submitted for review.

That means no bioequivalence data and no stability testing specific to that batch, so beyond-use dates are assigned by reference standards rather than by product testing.

Insurance coverage is inconsistent for the same reason, and many compounded prescriptions are paid in cash.

When compounding is the appropriate route

The decision belongs with a prescriber who knows why the commercial product will not serve, since compounding is a solution to a defined problem rather than a general alternative.

Copying a commercially available product is restricted, precisely because approved versions exist and have been evaluated.

Patients considering a compounded medicine should ask what standard the facility works to and whether the preparation is sterile or non-sterile, and raise clinical questions with the prescriber.